Impact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes

Abstract This study aimed to investigate the effect of patient engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes. We conducted a subanalysis of the telemonitoring device study in Kaiser Permanente Northern California members. We divide...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Min-Kyung Lee, Kwang-Hyeon Lee, Seung-Hyun Yoo, Cheol-Young Park
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/2a5c33872e194ca9880ad88a1f969a02
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2a5c33872e194ca9880ad88a1f969a02
record_format	dspace
spelling	oai:doaj.org-article:2a5c33872e194ca9880ad88a1f969a022021-12-02T12:32:26ZImpact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes10.1038/s41598-017-03842-22045-2322https://doaj.org/article/2a5c33872e194ca9880ad88a1f969a022017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03842-2https://doaj.org/toc/2045-2322Abstract This study aimed to investigate the effect of patient engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes. We conducted a subanalysis of the telemonitoring device study in Kaiser Permanente Northern California members. We divided the telemonitoring group into 53 frequent and 54 infrequent users based on self-monitoring of blood glucose (SMBG) frequency of the first 6 weeks. The frequency of SMBG transmitted from the telemonitoring device was examined over 24 weeks. Clinic and laboratory tests were collected at baseline, 6 weeks and 6 months. There was no significant difference in baseline HbA1c level between the two groups. After 6 months, change in HbA1c was −2.4 ± 1.6% among frequent users and −1.5 ± 1.5% among infrequent users (p = 0.003). The proportion of patients achieving target HbA1C level at 6 months was significantly higher among frequent users than among infrequent users. An increased frequency of SMBG was significantly correlated with a reduction in HbA1c at 6 months. In conclusion, initial active engagement in self-monitoring with a telemonitoring device could provide incremental improvement of glycemic control over 6 months.Min-Kyung LeeKwang-Hyeon LeeSeung-Hyun YooCheol-Young ParkNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Min-Kyung Lee Kwang-Hyeon Lee Seung-Hyun Yoo Cheol-Young Park Impact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes
description	Abstract This study aimed to investigate the effect of patient engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes. We conducted a subanalysis of the telemonitoring device study in Kaiser Permanente Northern California members. We divided the telemonitoring group into 53 frequent and 54 infrequent users based on self-monitoring of blood glucose (SMBG) frequency of the first 6 weeks. The frequency of SMBG transmitted from the telemonitoring device was examined over 24 weeks. Clinic and laboratory tests were collected at baseline, 6 weeks and 6 months. There was no significant difference in baseline HbA1c level between the two groups. After 6 months, change in HbA1c was −2.4 ± 1.6% among frequent users and −1.5 ± 1.5% among infrequent users (p = 0.003). The proportion of patients achieving target HbA1C level at 6 months was significantly higher among frequent users than among infrequent users. An increased frequency of SMBG was significantly correlated with a reduction in HbA1c at 6 months. In conclusion, initial active engagement in self-monitoring with a telemonitoring device could provide incremental improvement of glycemic control over 6 months.
format	article
author	Min-Kyung Lee Kwang-Hyeon Lee Seung-Hyun Yoo Cheol-Young Park
author_facet	Min-Kyung Lee Kwang-Hyeon Lee Seung-Hyun Yoo Cheol-Young Park
author_sort	Min-Kyung Lee
title	Impact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes
title_short	Impact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes
title_full	Impact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes
title_fullStr	Impact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes
title_full_unstemmed	Impact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes
title_sort	impact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes
publisher	Nature Portfolio
publishDate	2017
url	https://doaj.org/article/2a5c33872e194ca9880ad88a1f969a02
work_keys_str_mv	AT minkyunglee impactofinitialactiveengagementinselfmonitoringwithatelemonitoringdeviceonglycemiccontrolamongpatientswithtype2diabetes AT kwanghyeonlee impactofinitialactiveengagementinselfmonitoringwithatelemonitoringdeviceonglycemiccontrolamongpatientswithtype2diabetes AT seunghyunyoo impactofinitialactiveengagementinselfmonitoringwithatelemonitoringdeviceonglycemiccontrolamongpatientswithtype2diabetes AT cheolyoungpark impactofinitialactiveengagementinselfmonitoringwithatelemonitoringdeviceonglycemiccontrolamongpatientswithtype2diabetes
_version_	1718394085881937920

Impact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes

Ejemplares similares